We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QSI icon
12526
PUT
Quantum-Si Incorporated
QSI
$162M
$63K ﹤0.01%
13,400
-5,300
-28% -$25.8K
SHPW
12527
PUT
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$63K ﹤0.01%
2,750
-6,313
-70% -$150K
SCOBW
12528
DELISTED
ScION Tech Growth II Warrants
SCOBW
$63K ﹤0.01%
210,902
-26,865
-11% -$11.3K
FSSIW
12529
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$63K ﹤0.01%
204,584
-20,346
-9% -$8.88K
SREV
12530
PUT
DELISTED
ServiceSource International, Inc.
SREV
$63K ﹤0.01%
48,700
-34,200
-41% -$39.6K
AHG
12531
Akso Health Group
AHG
$1.09B
$62K ﹤0.01%
+36,856
New +$58.5K
BRFS
12532
PUT
DELISTED
BRF SA
BRFS
$62K ﹤0.01%
15,700
+5,700
+57% +$21.1K
LYEL icon
12533
PUT
Lyell Immunopharma
LYEL
$342M
$62K ﹤0.01%
610
-150
-20% -$18.2K
RCON icon
12534
CALL
Recon Technology
RCON
$2.32M
$62K ﹤0.01%
3,178
+1,295
+69% +$25.5K
REE
12535
PUT
DELISTED
REE Automotive
REE
$62K ﹤0.01%
1,087
+250
+30% +$25.5K
WDH
12536
Waterdrop
WDH
$359M
$62K ﹤0.01%
41,989
+26,215
+166% +$37.6K
PHLT
12537
DELISTED
Performant Healthcare Inc
PHLT
$62K ﹤0.01%
20,124
-102,124
-84% -$241K
PHXM
12538
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$62K ﹤0.01%
3,397
-3,936
-54% -$74.4K
TCRR
12539
PUT
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$62K ﹤0.01%
22,500
-25,300
-53% -$79.6K
FVT.WS
12540
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$62K ﹤0.01%
140,074
+74
+0.1% +$42
CLSD
12541
CALL
DELISTED
Clearside Biomedical
CLSD
$61K ﹤0.01%
1,773
-3,574
-67% -$107K
DLNG icon
12542
Dynagas LNG Partners
DLNG
$140M
$61K ﹤0.01%
+15,190
New +$46.4K
GDC icon
12543
GD Culture Group
GDC
$7.74M
$61K ﹤0.01%
9
-10
-53% -$72.8K
IMVT icon
12544
PUT
Immunovant
IMVT
$8.64B
$61K ﹤0.01%
11,100
-43,200
-80% -$269K
LGHL
12545
CALL
Lion Group Holding
LGHL
$729K
0
IMDX
12546
Insight Molecular Diagnostics
IMDX
$141M
$61K ﹤0.01%
2,043
+420
+26% +$13.4K
UONEK icon
12547
CALL
Urban One Class D
UONEK
$23.4M
$61K ﹤0.01%
1,190
-980
-45% -$42.2K
APTO
12548
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$61K ﹤0.01%
100
+54
+117% +$29.9K
EBACW
12549
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$61K ﹤0.01%
303,681
+64
+0% +$30
CO
12550
PUT
DELISTED
Global Cord Blood Corporation
CO
$61K ﹤0.01%
+15,800
New +$65.6K

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.